← Back to Search

experimental for Rheumatoid Arthritis

N/A
Waitlist Available
Led By Keri LeCompte, PharmD
Research Sponsored by Blue Cross Blue Shield of Vermont
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a lifestyle intervention can improve RA treatment when used alongside standard best practices.

Eligible Conditions
  • Rheumatoid Arthritis
  • Lifestyle Risk Reduction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in HAQ-2 score
Body Weight Changes
Secondary study objectives
Change in BMI
Change in RA-related costs for the study participant
Change in RA-related costs to the insurer
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: experimentalExperimental Treatment1 Intervention
standard of care + lifestyle intervention
Group II: controlActive Control1 Intervention
no intervention (control group)

Find a Location

Who is running the clinical trial?

Blue Cross Blue Shield of VermontLead Sponsor
Keri LeCompte, PharmDPrincipal InvestigatorBlue Cross Blue Shield of Vermont
~40 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top